|
|
Volumn 225, Issue , 2003, Pages 209-222
|
|
Assessment of anticolitic drugs in the trinitrobenzene sulfonic acid (TNBS) rat model of inflammatory bowel disease.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
ARGININE;
ENZYME INHIBITOR;
INDUCIBLE NITRIC OXIDE SYNTHASE;
N(G) NITROARGININE METHYL ESTER;
NITRIC OXIDE SYNTHASE;
NOS2 PROTEIN, RAT;
PEROXIDASE;
TRINITROBENZENESULFONIC ACID;
ANIMAL;
ANIMAL MODEL;
CHEMICALLY INDUCED DISORDER;
COLITIS;
DISEASE MODEL;
DRUG ANTAGONISM;
DRUG INSTILLATION;
DRUG SCREENING;
ENTERITIS;
ENZYMOLOGY;
MALE;
METABOLISM;
METHODOLOGY;
NEUTROPHIL;
ORAL DRUG ADMINISTRATION;
PATHOLOGY;
RAT;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
WESTERN BLOTTING;
WISTAR RAT;
ADMINISTRATION, ORAL;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
ARGININE;
BLOTTING, WESTERN;
COLITIS;
DISEASE MODELS, ANIMAL;
DRUG EVALUATION, PRECLINICAL;
ENZYME INHIBITORS;
INFLAMMATORY BOWEL DISEASES;
INJECTIONS, SUBCUTANEOUS;
INSTILLATION, DRUG;
MALE;
MODELS, ANIMAL;
NEUTROPHILS;
NG-NITROARGININE METHYL ESTER;
NITRIC OXIDE SYNTHASE;
NITRIC OXIDE SYNTHASE TYPE II;
PEROXIDASE;
RATS;
RATS, WISTAR;
TRINITROBENZENESULFONIC ACID;
|
|
EID: 0041766155
PISSN: 10643745
EISSN: None
Source Type: Journal
DOI: 10.1385/1-59259-374-7:209 Document Type: Review |
|
Times cited : (10)
|
|
References (62)
|
